52 results
424B3
COYA
Coya Therapeutics Inc
24 Jun 24
Prospectus supplement
5:31pm
Therapeutics, Inc. 2021 Equity Incentive Plan (the “Plan”); and
330,617 shares of common stock reserved for future issuance under the Plan.
RISK FACTORS
8-K
COYA
Coya Therapeutics Inc
8 May 24
Departure of Directors or Certain Officers
5:21pm
”). At the Annual Meeting, the Company’s stockholders approved an amendment (the “Amendment”) to the Company’s 2021 Equity Incentive Plan (the “Plan … Statements and Exhibits
Exhibits
Amendment No.1 to the Amended and Restated Coya Therapeutics, Inc. 2021 Equity Incentive Plan.
Cover Page Interactive
8-K
EX-10.1
COYA
Coya Therapeutics Inc
8 May 24
Departure of Directors or Certain Officers
5:21pm
Exhibit 10.1
FIRST AMENDMENT TO THE AMENDED AND RESTATED COYA THERAPEUTICS, INC.
2021 EQUITY INCENTIVE PLAN
ADOPTED BY THE COMPENSATION COMMITTEE … , Inc. Amended and Restated 2021 Equity Incentive Plan (the “Plan”) of Coya Therapeutics, Inc. (the “Company”), is made as of May 8, 2024. All
DEFA14A
wq35k bg5v5ef
28 Mar 24
Additional proxy soliciting materials
4:35pm
424B3
xhhzz3 5b
16 Jan 24
Prospectus supplement
4:06pm
S-3
9v7cbzmc05brsa9ch
4 Jan 24
Shelf registration
4:46pm
8-K
nbiuc amj0x0bh0t7z
20 Dec 23
Departure of Directors or Certain Officers
8:35am
8-K
z7o rb355a56yv
21 Aug 23
Former CEO and Chairman of the Board of Bayer Pharma AG, Dieter Weinand, joins Coya’s Board of Directors
5:01pm
8-K
EX-10.1
moelnj1i8611p
14 Jul 23
Departure of Directors or Certain Officers
5:01pm
8-K
EX-10.1
grwuu0d3
10 Jul 23
Departure of Directors or Certain Officers
5:08pm
8-K
8003bi6
10 Jul 23
Departure of Directors or Certain Officers
5:08pm
DEF 14A
e5zetl7436c vnp
19 May 23
Definitive proxy
4:31pm
424B4
9bk 8m0j6pvgiwo
12 May 23
Prospectus supplement with pricing info
4:16pm